Related references
Note: Only part of the references are listed.Kaposi's Sarcoma Herpesvirus MicroRNAs Induce Metabolic Transformation of Infected Cells
Ohad Yogev et al.
PLOS PATHOGENS (2014)
Regulation of mTORC1 and its impact on gene expression at a glance
Mathieu Laplante et al.
JOURNAL OF CELL SCIENCE (2013)
Pyruvate Kinase M2: Multiple Faces for Conferring Benefits on Cancer Cells
Mayumi Tamada et al.
CLINICAL CANCER RESEARCH (2012)
Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease
Thomas S. Uldrick et al.
CURRENT OPINION IN ONCOLOGY (2012)
Rapamycin With Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium Study
Susan E. Krown et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induction by Hypoxia and Hypoxia-Inducible Factors
Ravindra P. Veeranna et al.
JOURNAL OF VIROLOGY (2012)
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Dimitrios Anastasiou et al.
NATURE CHEMICAL BIOLOGY (2012)
Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer
Barbara Chaneton et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
Emerging roles of PKM2 in cell metabolism and cancer progression
Weibo Luo et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Gregg L. Semenza
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers
Dirk P. Dittmer et al.
FRONTIERS IN MICROBIOLOGY (2012)
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Weibo Luo et al.
CELL (2011)
Amplification of the Angiogenic Signal through the Activation of the TSC/mTOR/HIF Axis by the KSHV vGPCR in Kaposi's Sarcoma
Bruno C. Jham et al.
PLOS ONE (2011)
HIF-1: upstream and downstream of cancer metabolism
Gregg L. Semenza
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Journal of Cellular Biochemistry: Volume 110, Number 1, May 1, 2010
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma
Tao Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells
Tracie Delgado et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells
Matthew G. Vander Heiden et al.
SCIENCE (2010)
Kaposi's sarcoma and its associated herpesvirus
Enrique A. Mesri et al.
NATURE REVIEWS CANCER (2010)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1α to induce vascular endothelial growth factor expression
Young C. Shin et al.
CANCER RESEARCH (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
A potential α-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1α in normoxia
Qiliang Cai et al.
JOURNAL OF VIROLOGY (2007)
HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity
Huafeng Zhang et al.
CANCER CELL (2007)
Treatment of AIDS-Related Kaposi's sarcoma with interleukin-12: Rationale and preliminary evidence of clinical activity
Robert Yarchoan et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2007)
Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors
Patrick A. Carroll et al.
JOURNAL OF VIROLOGY (2006)
EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors
Qi-Liang Cai et al.
PLOS PATHOGENS (2006)
The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor
Akrit Sodhi et al.
CANCER CELL (2006)
Hypoxia-inducible factor-1α- and hypoxia-inducible factor-2α are expressed in Kaposi sarcoma and modulated by insulin-like growth factor-I
Sergiu-Bogdan Catrina et al.
CLINICAL CANCER RESEARCH (2006)
The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma
S Montaner et al.
CANCER RESEARCH (2006)
Pyruvate kinase type M2 and its role in tumor growth and spreading
S Mazurek et al.
SEMINARS IN CANCER BIOLOGY (2005)
Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression
J Vieira et al.
VIROLOGY (2004)
Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay
L Guedez et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes
S Montaner et al.
CANCER CELL (2003)
Molecular virology of Kaposi's sarcoma-associated herpesvirus
PS Moore et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2001)
Share Paper
